Northrop Grumman

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop

Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats.

The companies will use Luminex's xMAP technology to develop an automated biothreat detection tool for a US biosecurity network.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.